Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

Press/Media

Period	8 Nov 2020

Media coverage

Title	Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
Media name/outlet	Drug Genius
Country/Territory	United States
Date	8/11/20
URL	https://druggenius.com/clinical-trials/durvalumab-and-eribulin-in-her2-negative-metastatic-breast-cancer-and-recurrent-ovarian-cancer/
Persons	Amy Tiersten